Trials / Completed
CompletedNCT01008631
The Pharmacologic Profile of Sodium Thiosulfate in Renal Failure and Healthy Volunteers
The Pharmacologic Profile of Sodium Thiosulfate in Renal Failure and Healthy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- Insel Gruppe AG, University Hospital Bern · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
The pharmacokinetics of sodium thiosulfate in humans with different degrees of renal failure and in healthy volunteers will be after two single shot applications.
Detailed description
Two single shot applications of i.v. sodium thiosulfate will be given to dialysis patients. One application will be given immediately before a dialysis session and the second dose will be given after the consecutive dialysis session. In healthy volunteers sodium thiosulfate will be given only once. In both groups, dialysis patients and healthy volunteers, blood and urinary/dialysate samples will be collected at defined time points.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sodium thiosulfate | 6g of Sodium Thiosulfate are applicated in a short infusion over a time of 5 min |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2010-08-01
- Completion
- 2010-08-01
- First posted
- 2009-11-06
- Last updated
- 2011-10-13
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT01008631. Inclusion in this directory is not an endorsement.